Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

25 Jun 2018 07:00

RNS Number : 3200S
Phoenix Group Holdings
25 June 2018
 

 

 

Phoenix Group Holdings - Board Changes

 

The Board of Phoenix Group Holdings ("Phoenix") is pleased to announce the appointment of two new non-executive directors: Barry O'Dwyer and Campbell Fleming, both of Standard Life Aberdeen plc ("Standard Life Aberdeen").

 

These appointments will be effective from the date of completion of the acquisition by Phoenix of Standard Life Assurance Limited and are made in accordance with the terms of Phoenix's long-term strategic partnership with Standard Life Aberdeen.

 

Barry O'Dwyer is the CEO of Standard Life Aberdeen's Pensions & Savings business ("Standard Life"). Barry has held several senior roles at Standard Life since re-joining the company in 2013, and during his initial spell at Standard Life between 1988-2008. A Fellow of the Institute of Actuaries, Barry has 30 years of experience in the insurance industry, in a career which has also included senior roles at Prudential and HBOS.

 

Campbell Fleming is the Global Head of Distribution at Aberdeen Standard Investments, the asset management business of Standard Life Aberdeen. He joined Aberdeen Asset Management in August 2016 from Columbia Threadneedle Investments where he was the Chief Executive - EMEA and Global COO. Campbell is the Chair of the Investment Association Trade Committee and previously held senior positions at JP Morgan Asset Management.

 

Both Barry and Campbell will continue in roles with Standard Life Aberdeen once the acquisition completes.

 

Commenting on the Board changes, Henry Staunton, Phoenix Chairman said: "I am extremely pleased that Barry O'Dwyer and Campbell Fleming will be joining the Phoenix Board following completion of the acquisition. They bring substantial experience and executive skills complementary to those of our existing directors and very relevant to our evolving strategy. Their appointment reflects the significance of the relationship that we will hold with Standard Life Aberdeen going forward, both as a major shareholder but also as our strategic partner in the new business retirement space. We look forward to working with them as we realise our role as Europe's leading life consolidator."

 

Barry O'Dwyer was a director of Standard Life plc from 1 March 2017 to 14 August 2017. No other information is required to be notified under Listing Rule 9.6.13R.

 

 

Enquiries

 

Equity Investors/Analysts:Claire Hawkins, Head of Investor Relations, Phoenix+44 (0) 20 3735 0575

 

MediaAndy Donald and Vikki Kosmalska, Maitland + 44 (0) 20 7379 5151

 

Shellie Wells, Head of Corporate Communications, Phoenix Group

+44 (0) 203 735 0922/ +44 7872 414137

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUSRWRWOANUAR
Date   Source Headline
24th Feb 20262:25 pmRNSChange of Company Name
18th Feb 20262:12 pmRNSAppointment of Corporate Broker
6th Feb 20261:52 pmRNSDirector/PDMR Shareholding
2nd Feb 202611:02 amRNSTotal Voting Rights
6th Jan 20261:31 pmRNSDirector/PDMR Shareholding
2nd Jan 202611:06 amRNSTotal Voting Rights
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
12th Dec 20252:49 pmRNSBlock listing Return
8th Dec 202511:08 amRNSDirector/PDMR Shareholding
1st Dec 20251:57 pmRNSTotal Voting Rights
24th Nov 20255:20 pmRNSBlock Listing Application
24th Nov 20257:09 amRNSLIST 2025 Results Show Robust Capital Position
6th Nov 20253:47 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:01 pmRNSTotal Voting Rights
31st Oct 20253:10 pmRNSDirector/PDMR Shareholding
7th Oct 20251:20 pmRNSDirector/PDMR Shareholding
1st Oct 202512:38 pmRNSTotal Voting Rights
17th Sep 20252:40 pmRNSPublication of a Supplementary Prospectus
10th Sep 20252:51 pmRNSDirector/PDMR Shareholding
8th Sep 20255:23 pmRNSDirector/PDMR Shareholding
8th Sep 20257:00 amRNS2025 Interim Results
1st Sep 202510:00 amRNSTotal Voting Rights
18th Aug 202510:00 amRNSBoard Changes
6th Aug 202512:53 pmRNSDirector/PDMR Shareholding
1st Aug 202510:18 amRNSTotal Voting Rights
8th Jul 20253:31 pmRNSDirector/PDMR Shareholding
1st Jul 202512:26 pmRNSTotal Voting Rights
26th Jun 20259:00 amRNSBoard Changes
13th Jun 20253:00 pmRNSPublication of Prospectus
12th Jun 20252:43 pmRNSBlock listing Return
9th Jun 202512:25 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:44 pmRNSTotal Voting Rights
23rd May 20253:02 pmRNSDirector/PDMR Shareholding
20th May 202510:00 amRNSDirector Declaration
13th May 20253:34 pmRNSResult of AGM
7th May 20254:20 pmRNSDirector/PDMR Shareholding
1st May 202510:33 amRNSTotal Voting Rights
10th Apr 20252:37 pmRNSDirector/PDMR Shareholding
8th Apr 20253:10 pmRNSDirector/PDMR Shareholding
3rd Apr 20251:35 pmRNSNotice of AGM
1st Apr 20252:52 pmRNSDirector/PDMR Shareholding
1st Apr 20252:42 pmRNSTotal Voting Rights
26th Mar 20253:46 pmRNSDirector/PDMR Shareholding
24th Mar 20255:43 pmRNSDirector/PDMR Shareholding
21st Mar 202511:56 amRNSDirector/PDMR Shareholding
20th Mar 20254:19 pmRNSDirector/PDMR Shareholding
19th Mar 20254:26 pmRNSDirector/PDMR Shareholding
19th Mar 20252:15 pmRNSDirector/PDMR Shareholding
17th Mar 20257:00 amRNS2024 Annual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.